Furthermore, NSUN2 up-regulates PIK3R2 and enhances its mRNA stability, leading to the activation of the PI3K-AKT signaling pathway and promoting the malignant progression of lung adenocarcinoma, highlighting its potential as a therapeutic target (187). This evidence concerns the gene AKT1 and lung adenocarcinoma.